3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neoplasm Metastasis
4
Colorectal Neoplasms
2
Pancreatic Neoplasms
1
Neoplasms
1
HER2-Positive Primary Breast Cancer
1
Gastrointestinal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Adenocarcinoma
1
Interventions
olaparib
4
Bevacizumab
3
niraparib
2
defactinib
2
Paclitaxel
2
Immunoglobulin G
2
Disulfides
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sodium thiosulfate
1
sapanisertib
1
rucaparib
1
relatlimab
1
relacorilant
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
durvalumab
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Ovarian Neoplasms
×
trastuzumab deruxtecan
×
Clear all
No trials found.